Pengukuran Risiko Kardiovaskular berbasis Non Invasive Vascsular Analyzer (NIVA) untuk Masyarakat Umum (PKM)
Researcher Name (Team Leader)

Astri Handayani



Activity Summary

The number of people suffering from cardiovascular disease in Indonesia is expected to increase from year to year (Riskesdas, 2018). In 2018, it was recorded that 15 out of 1000 Indonesians suffered from cardiovascular disease, with a death rate of 650,000 individuals per year (Ministry of Health of the Republic of Indonesia, 2023). Mass identification of PKD risk in asymptomatic subclinical populations is one of the greatest challenges in public health today. One of the physiological indicators that can be used as an identification tool is vascular aging (VA), which can be estimated by measuring pressure and blood flow in the patient's hands and feet. The Non Invasive Vascular Analyzer (NIVA) is a tool for measuring 15 certified VA parameters that has passed clinical trials that has been developed by KK Biomedical Engineering since 2013. VA has been shown to be strongly correlated with cardiovascular risk, especially in asymptomatic subclinical populations. This community service activity is directed as a continuation of the efforts of the Biomedical Engineering Group since 2023 to introduce the potential of NIVA through free measurement sessions accompanied by cardiovascular health education by doctors. Taking place at the Biomedical Engineering Laboratory, Labtek 8, 3rd floor, ITB, this activity targets 50 individuals from the general public. Based on the NIVA measurement results, each participant will also be given counseling on cardiovascular risk management according to their individual risk profile. With this activity, it is hoped that more and more of the population will understand their cardiovascular risks and be well educated to manage these risks.



Target

Facilitate cardiovascular risk measurement in the general population, especially in subclinical populations without PKD symptoms. Facilitate education on cardiovascular risk management in the general public, especially in subclinical populations without PKD symptoms.



Testimonials

More and more of the general population understands their cardiovascular risks and is well educated to manage those risks. As a promotional tool for NIVA, a cardiovascular health diagnostic tool that is completely designed and produced domestically.